Biofrontera Inc. (NASDAQ:BFRIW) Short Interest Update

Biofrontera Inc. (NASDAQ:BFRIW) was the target of a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 6,628 shares, an increase of 88.7% from the April 30th total of 3,513 shares. Based on an average daily volume of 13,984 shares, the days-to-cover ratio is presently 0.5 days.

Biofrontera Trading Up 34.5%

NASDAQ BFRIW opened at $0.03 on Thursday. Biofrontera has a twelve month low of $0.02 and a twelve month high of $0.28. The stock has a fifty day simple moving average of $0.04 and a 200-day simple moving average of $0.05.

Biofrontera Company Profile

Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.

The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.